Weir, Robin A P <br/><br/>
Interleukin-21--a biomarker of importance in predicting myocardial function following acute infarction?  [electronic resource] 

 -  Cytokine  Oct 2012 
 - 220-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0023 
<br/><br/><label>Standard No.: </label>10.1016/j.cyto.2012.06.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Double-Blind Method<br/>Eplerenone<br/>Female<br/>Humans<br/>Interleukins--blood<br/>Male<br/>Matrix Metalloproteinase 2--blood<br/>Matrix Metalloproteinase 3--blood<br/>Matrix Metalloproteinase 9--blood<br/>Middle Aged<br/>Mineralocorticoid Receptor Antagonists--therapeutic use<br/>Multivariate Analysis<br/>Myocardial Infarction--blood<br/>Predictive Value of Tests<br/>Spironolactone--analogs & derivatives<br/>Tissue Inhibitor of Metalloproteinase-1--blood<br/>Tissue Inhibitor of Metalloproteinase-2--blood<br/>Tissue Inhibitor of Metalloproteinases--blood<br/>Treatment Outcome<br/>Ventricular Dysfunction, Left--blood<br/>Ventricular Remodeling--drug effects<br/>Tissue Inhibitor of Metalloproteinase-4<br/>Interleukin-21